Time-Restricted Eating for Cancer

This trial explores whether eating within a specific daily time frame can improve cancer treatment outcomes and overall health. It targets individuals with solid tumors who have undergone surgery and are beginning additional treatments such as chemotherapy or radiation. Participants will either adopt time-restricted eating (consuming all meals within an 8-hour window) or maintain their usual eating habits. The trial seeks individuals who have had surgery for solid tumors and are about to start further treatment. As an unphased trial, it provides a unique opportunity to contribute to research that could enhance future cancer care strategies.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that time-restricted eating (TRE) might be a safe option for people undergoing cancer treatment. In one study, patients who followed TRE adhered to the eating schedule well (67–98% of the time) and reported feeling better during their treatment.

Another study found that TRE can enhance the effectiveness of chemotherapy and reduce its side effects, potentially helping patients manage their cancer treatments more easily. TRE has also improved metabolic health, which is linked to better overall outcomes during cancer care.

Researchers are excited about time-restricted eating (TRE) for cancer because it offers a unique approach by altering the timing of food intake rather than focusing on specific drugs or chemotherapy. Unlike traditional cancer treatments that often involve medication or invasive procedures, TRE uses a natural cycle of eating and fasting, which could potentially improve metabolic health and enhance the body's natural defenses against cancer. This method is intriguing because it might reduce side effects and improve quality of life for patients, offering a new complementary strategy alongside existing treatments.

This trial will compare time-restricted eating (TRE) with a control group to evaluate its effects on cancer treatment. Research has shown that TRE might enhance the effectiveness of cancer treatments. Animal studies have found that fasting can improve chemotherapy success and reduce its side effects. TRE, a type of fasting where eating is limited to certain hours of the day, is easier to follow than fasting for an entire day. It may protect healthy cells and weaken cancer cells. Some research also suggests that TRE can improve insulin management and reduce other health issues, which could be beneficial during cancer treatments. Additionally, TRE has proven easy for participants to maintain and can enhance their quality of life.¹²³⁶⁷